Research and Development

The Research and Development team at Nucleix is responsible for pioneering innovative cancer diagnostic panels utilizing epigenetic biomarkers. Their work involves cutting-edge research, bioinformatics analysis, and product development to advance the detection and diagnosis of various cancer types. This team, composed of scientists, data scientists, and product development experts, aims to translate scientific discoveries into clinically viable diagnostic tools.